CPC A01N 59/20 (2013.01) [A01N 25/06 (2013.01); A01N 59/14 (2013.01); B82Y 5/00 (2013.01); B82Y 30/00 (2013.01); B82Y 40/00 (2013.01)] | 12 Claims |
1. An antiviral nano-formulation comprising:
a. functionalized-Carbon Quantum Dots (F-CQDs) in a range of 20-500 ppm of a total volume of the nano-formulation;
b. metal or metal oxide nanoparticles in a range of 20-500 ppm of the total volume of the nano-formulation; and
c. a cross-linkable polymer (CL-Pol) in a range of 50-1000 ppm of the total volume of the nano-formulation, wherein the nano-formulation is a nano-emulsion or an aerosol spray,
wherein the cross-linkable polymer is a synthetic polymer or a natural polymer, and wherein the synthetic polymer is selected from the group consisting of polycaprolactone (PCL-PEG), poly (lactic-co-glycolic acid-PEG) (PLGA-PEG), and poly tricarboxylic or dicarboxylic acid-b-PEG, and the natural polymer is selected from the group consisting of chitosan, gelatin, collagen, and a combination thereof.
|